Corporate Integrity Agreement Mandates That Pfizer GC Can No Longer Be Compliance Chief

As part of its settlement with the DOJ, Pfizer must now adhere to a corporate integrity agreement that dictates its General Counsel can longer operate as the head of compliance. Instead, the chief compliance officer will now report directly to Pfizer’s CEO.

Here are some related links and excerpts for more background:

Pfizer GC No Longer Oversees Compliance

Pfizer Inc.’s general counsel will no longer oversee the company’s compliance program, under the terms of the company’s $2.3 billion settlement agreement resolving allegations that Pfizer’s executives and sales staff illegally marketed the painkiller Bextra and several other drugs.

Instead, the chief compliance officer at the world’s largest drug maker will report directly to the CEO. The move is required by Pfizer’s corporate integrity agreement with the office of the inspector general of the U.S. Department of Health and Human Services, which is part of the company’s civil and criminal settlement with the U.S. Department of Justice.

>>>read entire article at Law.com

——————–

Pfizer GC Loses Compliance Chief Role Under $2.3B Drug Marketing Settlement

The new reporting scheme should eliminate conflicts of interest and prevent in-house counsel at Pfizer from reviewing or editing reports required by the settlement agreement, says chief counsel Lewis Morris of the inspector general’s office.

>>>read entire article at ABA Journal

——————–

Additional Resources:

• Read the entire corporate integrity agreement between Pfizer and the Department of Health and Human Services.
• Complete list of corporate integrity agreements at the Officer of the Inspector General.

Tags: chief compliance officer, compliance program, corporate integrity agreement, Department of Health and Human Services, DOJ, GC, general counsel, Inspector General, Pfizer, Pfizer settlement